Goldbug100 - Pharmalink International Limited - 2010 H1 results

13 August 2010 - Unaudited Consolidated Financial Results for the Half Year Ended 30 June 2010

. Sales increased 98.5% to US$6,990,345 (2009 US$3,521,309)

. Net profit increased 194.6% to US$2,189,007 (2009) US$742,977)

. Net profit margin increased to 51.4% (2009 41.8%)

. Total assets increased 45.8% to US$10,049,085 (2009 US$6,503,508)

. Net asset value per share increased 45.8% to $US$6.11 (2009 US$4.55)

. Cash and deposits increased 31.5% to US$2,498,339 (2009 US$1,898,495) The Company has not debt

. Net profit per share was US$1.53 (2009 US$0.52)

. Interim dividend US$0.50 to be paid to shareholder in September 2010

Sales increased in the USA Great Health Works (GHW) by 250% - Sales to European Distributors increased by 29.2% - New Zealand saw a rise of 371.29% - Poland 880.13% - Canada 289.75% - Slovak Republic 413.06% as did most markets

The shares are traded over the counter in Hong Kong., the original shareholders having been shareholders in Special Assets Limited (HK.B12179)

Company´s websites www.lyprinol.com and www.OmegaXL.com - Email skwok@sal.com.hk

Tel: (852) 2537-8088

These posts on twitter could be of interest

0 more result since you started searching. Refresh to see them.

1. nichols1936 - Pharmalink www.lyprinol.com/ - mussel oil relieves arthritic inflamation. sales + 16.5% - assets + 1.8% - profits - 7.9% - Dividend US$.0.40
   
   
2. nichols1936 - Pharmalink www.lyprinol.com/ report product used by triathletes, marathon runners & cyclists - an improvement of lung capacity of up to 10%